Munich - Delayed Quote EUR

Halozyme Therapeutics Inc (RV7.MU)

46.40
-0.21
(-0.45%)
As of 8:00:37 AM GMT+2. Market Open.

Key Executives

Halozyme Therapeutics Inc

Description

Corporate Governance

Halozyme Therapeutics Inc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 4, 2025 at 10:59 AM UTC - August 8, 2025 at 12:00 PM UTC

Halozyme Therapeutics Inc Earnings Date

Recent Events